Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The Company’s segments include Banking and Diagnostics. The banking segment comprises the collection, processing, and banking of biological materials. The diagnostics segment comprises diagnostics testing services. Its banking services include cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue, and others. Its diagnostic testing services include newborn genetic screening, pediatric vision screening, pediatric ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing, lifestyle genetic screening, and newborn metabolic screening. Its Moms Up is a mobile app offering pregnancy, as well as parenting resources for moms and moms-to-be in Asia.
Follow-Up Questions
What is the price performance of CLIFF stock?
The current price of CLIFF is $0.0901, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Cordlife Group Ltd?
Cordlife Group Ltd belongs to Health Care industry and the sector is Health Care
